Pharmafile Logo
Pharmafocus logo
Advanced Search

New skills and ways of working in healthcare comms

March 10, 2011
Medical Communications HCA, Healthcare Communications Association, benchmarking

A new report from the Healthcare Communications Association (HCA) indicates a trend towards new skills and ways of working, as …

Feature

Novartis’ COPD drug recommended for FDA approval

March 10, 2011
Sales and Marketing Arcapta Neohaler, COPD, Novartis, Onbrez Breezhaler, QAB143, chronic obstructive pulmonary disease, indacterol

Novartis has won the backing of an FDA advisory committee for its chronic obstructive pulmonary disease (COPD) treatment QAB149. The …

News

‘This R&D Malarkey, it’s broken, isn’t it?’

March 9, 2011
Research and Development R&D, Sandwich, research productivity

Pharmaceutical industry leaders are increasingly admitting that the very low productivity of its R&D pipelines is unsustainable – but no …

Feature

Francois Meyer to head up TxCell

March 9, 2011
Research and Development Francois Meyer, TxCell, appointment, research and development

French biotech TxCell has appointed François Meyer as chief executive. He has more than 25 years of pharma and biotech …

Appointment

Janssen’s monthly antipsychotic approved in Europe

March 9, 2011
Sales and Marketing Janssen, Xeplion, antipsychotic, injectible antipsychotic, paliperidone palmitate, schizophrenia

Janssen’s injectable antipsychotic Xeplion has been approved by the European Commission for the treatment of schizophrenia. There is no cure …

News

Actelion defends itself against investor aggression

March 9, 2011
Sales and Marketing Actelion, Tracleer, almorexant

Swiss biotech firm Actelion is mounting a defence of its management board and strategy following an offensive by a shareholder …

News

Finance a bigger worry than reform for NHS chiefs

March 9, 2011
Acute Trusts, NHS, NHS Confederation, NHS finances, NHS reforms

NHS leaders are more concerned with how they are going to balance the books this year than with the reorganisation …

News
AstraZeneca

AZ partners with Galderma on psoriasis research

March 9, 2011
Research and Development AZ, AstraZeneca, Galderma, dermatology, psoriasis

AstraZeneca has signed a five-year deal with dermatology specialist Galderma Pharma to develop new treatments for conditions including psoriasis. It …

News

Health secretary defends NHS reform to doctors

March 8, 2011
GP consortia, Health and Social Reform bill, NHS, NHS reforms

Health secretary Andrew Lansley has defended his reorganisation of the NHS to doctors, saying it will cut unnecessary levels of …

News

Eisai confirms 20% cut in US workforce

March 8, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Aricept, Eisai, Halaven, US, donepezil, eribulin, pharma job cuts

Eisai’s planned job cuts will fall heaviest on its US operations, where 20% of the workforce will be let go …

News

Sophie Gibbs and Naumaan Mayet join Pan

March 8, 2011
Medical Communications, Sales and Marketing Naumaan Mayet, Pan, Pan Advertising, Sophie Gibbs, appointment, medical communications

Pan Advertising has recruited two new members to its account handling team.Sophie Gibbs returns to the agency as an account …

Appointment
Merck & Co workers protest job cuts

Merck says sale of Oss facility would be too expensive

March 8, 2011
Manufacturing and Production, Research and Development Holland, Merck & Co, Oss, Oss pharma research, Pantarhei Bioscience

The debate around the closure of Merck & Co’s R&D and manufacturing unit in Oss, the Netherlands, rumbles on, with …

News

AZ stops making Pulmicort pMDI inhaler

March 8, 2011
Manufacturing and Production AZ, AstraZeneca, Pulmicort, Pulmicort pMDI, Skyepharma, asthma, asthma inhaler, budesonide

AstraZeneca has discontinued production of its Pulmicort pMDI asthma inhaler because of manufacturing issues, and looks set to exit from …

News

Helsinn expands high-potency plant with cytotoxics suite

March 8, 2011
Manufacturing and Production APIs, CMOs, GMP, Helsinn, Helsinn Advanced Synthesis, Swiss pharma contract manufacturing, contract manufacturing, high-potency APIs

Helsinn is on track to complete construction of a new manufacturing plant for cytotoxic active pharmaceutical ingredients in Biasca, Switzerland, …

News

Pharma manufacturing news in brief

March 8, 2011
Manufacturing and Production Bristol-Myers Squibb, CSM GlobalPharma, Carbogen Amcis, Quotient Clinical, SCM Pharma, WuXi PharmaTech

Facility updates from Bristol-Myers Squibb, WuXi PharmaTech, Quotient Clinical, CSM GlobalPharma and SCM Pharma, plus a reorganisation of Carbogen Amcis’ …

News

Ethical practices – pharma’s obligation

March 8, 2011
Research and Development, Sales and Marketing ethics, industry relations, industry reputation

Pharmaceutical companies are not charities, and neither is any other business, by definition. Capitalism as a recognised system has been …

Feature

Service Insight: Emerging markets – a business development task or extreme fishing?

March 7, 2011
Sales and Marketing Service Insight, Surelines Ltd, emerging markets

SERVICE INSIGHTEmerging markets, new business; call it what you will but invariably the responsibility for grasping this nettle falls to …

Feature
GlaxoSmithKline's London headquarters

GSK ends neuroscience research alliance

March 7, 2011
Research and Development GSK, GlaxoSmithKline, Targacept, neuronal nicotinic receptors, neuroscience research

GlaxoSmithKline has severed a strategic alliance formed in July 2007 with US biopharma company Targacept. GSK forked out $45 million …

News

GSK adds former Merck CFO to board

March 7, 2011
Sales and Marketing GSK, GlaxoSmithKline, Judy Lewent, Stacey Cartwright, appointment, sales and marketing

GlaxoSmithKline has appointed Judy Lewent to its board as a non-executive director. She has previously served as an executive VP …

Appointment

Government injects £775m into NHS translational research

March 7, 2011
Research and Development ABPI, Kent, NHS research, Pfizer research Kent, Sandwich, Science and Technology Select Committee, translational research

The government has pledged around £775 million for translational research, saying it will help modernise the health service and support …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026